🇺🇸 FDA
Pipeline program

A trial comparing how the body absorbs and gets rid of petadeferitrin taken as two different forms in healthy people

Petadeferitrin-BA-01

Phase 1 other active

Quick answer

A trial comparing how the body absorbs and gets rid of petadeferitrin taken as two different forms in healthy people for Iron overload from thalassemia, transfusion-dependent myelodysplastic syndromea and haemolysis is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Iron overload from thalassemia, transfusion-dependent myelodysplastic syndromea and haemolysis
Phase
Phase 1
Modality
other
Status
active

Clinical trials